Free Trial

HilleVax (HLVX) Stock Price, News & Analysis

HilleVax logo
$2.08 0.00 (0.00%)
Closing price 04:00 PM Eastern
Extended Trading
$2.08 +0.00 (+0.24%)
As of 06:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About HilleVax Stock (NASDAQ:HLVX)

Key Stats

Today's Range
$2.07
$2.10
50-Day Range
$1.86
$2.17
52-Week Range
$1.34
$2.17
Volume
2.32 million shs
Average Volume
348,541 shs
Market Capitalization
$104.29 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.00
Consensus Rating
Hold

Company Overview

HilleVax Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
35th Percentile Overall Score

HLVX MarketRank™: 

HilleVax scored higher than 35% of companies evaluated by MarketBeat, and ranked 773rd out of 949 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    HilleVax has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    HilleVax has only been the subject of 1 research reports in the past 90 days.

  • Read more about HilleVax's stock forecast and price target.
  • Earnings Growth

    Earnings for HilleVax are expected to grow in the coming year, from ($2.64) to ($1.92) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of HilleVax is -1.45, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of HilleVax is -1.45, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    HilleVax has a P/B Ratio of 0.71. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about HilleVax's valuation and earnings.
  • Percentage of Shares Shorted

    1.95% of the float of HilleVax has been sold short.
  • Short Interest Ratio / Days to Cover

    HilleVax has a short interest ratio ("days to cover") of 1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in HilleVax has recently decreased by 3.20%, indicating that investor sentiment is improving.
  • Dividend Yield

    HilleVax does not currently pay a dividend.

  • Dividend Growth

    HilleVax does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.95% of the float of HilleVax has been sold short.
  • Short Interest Ratio / Days to Cover

    HilleVax has a short interest ratio ("days to cover") of 1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in HilleVax has recently decreased by 3.20%, indicating that investor sentiment is improving.
  • News Sentiment

    HilleVax has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.99 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for HilleVax this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, HilleVax insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    24.90% of the stock of HilleVax is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    86.42% of the stock of HilleVax is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about HilleVax's insider trading history.
Receive HLVX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HilleVax and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

HLVX Stock News Headlines

HilleVax, Inc. Reports Q2 2025 Financial Results
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.tc pixel
HilleVax Announces Merger Agreement with XOMA
HilleVax Reports Second Quarter 2025 Financial Results
See More Headlines

HLVX Stock Analysis - Frequently Asked Questions

HilleVax's stock was trading at $2.07 on January 1st, 2025. Since then, HLVX shares have increased by 0.5% and is now trading at $2.08.

HilleVax, Inc. (NASDAQ:HLVX) issued its quarterly earnings results on Wednesday, August, 6th. The company reported ($0.11) earnings per share for the quarter, beating the consensus estimate of ($0.14) by $0.03.

HilleVax (HLVX) raised $200 million in an IPO on Friday, April 29th 2022. The company issued 11,765,000 shares at a price of $16.00-$18.00 per share.

HilleVax's top institutional investors include EcoR1 Capital LLC (4.83%), Balyasny Asset Management L.P. (1.95%), Geode Capital Management LLC (0.51%) and Stonepine Capital Management LLC (0.45%). Insiders that own company stock include Life Sciences X LP Frazier, Aditya Kohli, Astrid Borkowski, Shane Maltbie and Sean Mcloughlin.
View institutional ownership trends
.

Shares of HLVX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that HilleVax investors own include JPMorgan Chase & Co. (JPM), Tesla (TSLA), Netflix (NFLX), NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META) and Home Depot (HD).

Company Calendar

Last Earnings
8/06/2025
Today
8/28/2025
Next Earnings (Estimated)
11/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:HLVX
CIK
1888012
Fax
N/A
Employees
20
Year Founded
N/A

Price Target and Rating

High Price Target
$2.00
Low Price Target
$2.00
Potential Upside/Downside
-4.1%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.43)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$147.27 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-34.29%
Return on Assets
-28.50%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
26.39
Quick Ratio
26.39

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.95 per share
Price / Book
0.71

Miscellaneous

Outstanding Shares
50,140,000
Free Float
37,656,000
Market Cap
$104.54 million
Optionable
Not Optionable
Beta
0.77
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:HLVX) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners